Table 1.
Author/Year | Country | Type of study | Population | Total Patients (n) |
Age | Intervention arm(s)/N | Control arm/N | Outcome | Adverse events |
---|---|---|---|---|---|---|---|---|---|
Bortolotti, M/2000 | Italy | RCT | Patients affected by achalasia with an esophageal diameter of < = 5 cm | 14 | Mean age, 41 years; age range, 21–64 years | A 50-mg tablet of sildenafil | Placebo |
Sildenafil inhibits the contractile activity of the esophageal musculature of patients with achalasia, decreasing lower esophageal sphincter tone and residual pressure as well as contraction amplitude. |
No side effects were observed, except for headache in one case. |
Bortolotti, M/2001 | Italy | RCT | Healthy subjects | 16 | 34 years, age range 22–56 | A 50-mg tablet of sildenafil | Placebo |
Sildenafil markedly inhibits the motor activity of the esophageal musculature by decreasing LES pressure, wave amplitude, and propagation velocity |
No side effects were observed, except for headache in one case. |
Rhee, P.L./2001 | Korea | Before/ After | Healthy male adult volunteers | 8 | Mean age = 30.5 years | A 50-mg tablet of sildenafil | N.A |
LES resting pressure significantly decreased after sildenafil infusion. The body’s peristaltic amplitude gradually decreased and eventually disappeared |
No serious side effects were noticed |
Bortolotti, M. /2002 | Italy | RCT | Patients with symptomatic hypertensive LES | 14 | Mean age 35 years, range 28–55 | A 50-mg tablet of sildenafil | Placebo |
Sildenafil inhibits the lower oesophageal sphincter tone and pressure wave amplitude of patients with symptomatic hypertensive LES |
No side effects were observed |
Eherer, A. J./2002 | Austria | Before/ After | Healthy subjects, nutcracker esophagus, hypertensive LES, and achalasia patients |
Healthy subjects: 6, Patients with esophageal disorder: 11 |
Normal subjects: aged 26–30 years, Patients: aged 27–57 years |
A 50-mg tablet of sildenafil | Placebo |
Sildenafil lowers LOS pressure and propulsive forces in the body of the esophagus of healthy subjects as well as in patients with nutcracker oesophagus, hypertensive LOS, and achalasia. |
Two patients experienced side effects and did not want to continue treatment. (Side effects included: headaches, dizziness, fatigue, sleep disturbances, feeling of tightness in the chest at night.) |
Mathis, C./2002 | USA | Before/ After |
Patients diagnosed with hypertensive LES |
N.A | N.A | Sildenafil (50 mg) dissolved | N.A | Sildenafil inhibits LES tone and the amplitude of contractions of the distal esophageal body in patients with hypertensive LES. | N.A |
Lee, J. I. / 2003 | Korea | Before/ After | Healthy subjects, patients with nutcracker esophagus |
Healthy subjects: 8, Patients with nutcracker esophagus: 9 |
Healthy subjects: 24.3 years, Patients with nutcracker esophagus: 44.7 years |
0.8 mg/kg sildenafil dissolved in 20 mL of water | distilled water |
In both healthy subjects and patients with nutcracker esophagus, sildenafil decreased resting LOS pressure and the amplitude of peristaltic pressure waves at 3, 8 and 13 cm above LOS. Sildenafil also prolonged the duration of LOS relaxation. It had no effect on the velocity of peristalsis or the amplitude of peristaltic pressure waves 18 cm above LOS. |
No noticeable side-effects reported |
Kim, H. S. / 2006 | Korea | Before/ After | Healthy subjects | 8 | Mean age : 38.5 years | 50-mg dose of sildenafil | N.A |
Sildenafil decreased the resting lower esophageal sphincter pressure and prolonged the duration of lower esophageal sphincter relaxation for the 45 min following its ingestion, and does not induce gastro-oesophageal reflux. |
N.A |
Lee, T. H./ 2012 | Korea | RCT | Healthy volunteers | 16 | Mean age : 31.4 years | 10 mg vardenafil | Water |
Vardenafil decreased resting and residual LES pressures, distal esophageal contraction, and bolus transit. |
N.A |
Rodriguez, R. / 2013 | N.A | Before/ After | Healthy volunteers, patients with type II/III achalasia, and hypertensive peristalsis | 20 |
Healthy group: mean age 27.5 Patients: mean age 45 years |
Single dose of 20 mg tadalafil | N.A |
Tadalafil is a 5-PDE that induce a prolonged and sustained effect on esophageal contractions, is well tolerated and it could be a promising drug in the management of esophageal motor disorders. |
Mild headache |
Guevara-Morales /2014 | N/A | Before/ After | Achalasic Patients | 12 | N/A | 20 mgs tadalafil | N/A | Tadalafil may significantly reduced LES pressure and IRP in achalasia patients, and patients with Type 2 Achalasia had a better response. | Headache and back pain |
Costa, T./2020 | Brazil | Before/ After | Healthy volunteers | 22 | Mean age : 38.1 years | 50 mg sildenafil | N.A |
Sildenafil caused a significant reduction in distal contractile integral and integrated relaxation pressure in the lower esophageal sphincter. In the proximal esophagus the alteration in distal esophageal contraction caused a significant increase in contraction length, contractile integral, and contraction duration; suggesting an adaptive compensation of the proximal esophagus for the effect of sildenafil on distal esophageal motility. |
There was no adverse event after administration of sildenafil. |
Wong, M. W. /2020 | Taiwan | RCT | Healthy subjects | 15 | Mean age: 27 years | 50 mg sildenafil | Placebo |
Sildenafil attenuates esophagogastric junction barrier function, resting LES pressure, and LES relaxation. Both esophageal body contractility and contraction reserve are in- hibited by sildenafil in healthy adults. |
Significant adverse effects were not observed in patients. |
Wong, M. W. /2021 | Taiwan | RCT | Healthy subjects | 17 | Mean age : 30.2 years | 50 mg sildenafil | Placebo |
Sildenafil reduces both the success rate and the vigor of secondary peristalsis, similar to that seen with primary peristalsis. |
N.A |